Not a hope. Their debt is worse than ours were recently. They’re struggling. why would you wish to be further involved with a company who were going to be first to gain FDA approval for Haloette 4 years later they were last. This after three failures. Their major shareholder ex MD / CEO now an advisor facing criminal insider trading charges. I wouldn’t even be bothered with Donesta . ( have you checked out forthcoming menopausal treatments. ) Huge !! Even Nextellis is a company breaking ( not making as promised) product to establish. Cash burner ! By my sums they need to increase existing sales projections by 400% to break even on . This doesn’t take into account $200-250m it has already cost us.
MYX Price at posting:
$3.84 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)